Ilona Argirion

Ilona Argirion is a researcher at the German Cancer Research Center (DKFZ) specializing in cancer epidemiology with a focus on the intersection of infectious diseases and cancer development. Her work primarily investigates viral carcinogenesis and nutritional factors in cancer risk assessment.

Dr. Argirion's research interests include:

• Cancer Epidemiology - examining population-level patterns and determinants of cancer
• Infectious Disease Oncology - studying how pathogens like Epstein-Barr Virus contribute to cancer development
• Viral Carcinogenesis - investigating molecular mechanisms linking viral infections to malignancies
• Nutritional Epidemiology - assessing dietary influences on cancer risk
• Molecular Serology - developing and applying antibody-based diagnostic approaches

Her recent publications reveal a strong emphasis on biomarker development for cancer detection and understanding environmental risk factors. The Epstein-Barr Virus antibody research demonstrates potential for improved diagnostic tools for nasopharyngeal carcinoma, while her work on tea and coffee consumption contributes to understanding modifiable risk factors for biliary tract cancers. Both studies employ sophisticated epidemiological methods and large-scale data analysis.

Dr. Argirion actively participates in major collaborative research initiatives including the Head and Neck 5000 clinical cohort and the international Biliary Tract Cancers Pooling Project, working alongside researchers from multiple institutions across different countries to advance cancer research through pooled data analysis.